Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD274 | Q9NZQ7 | 9/20 | 0.66 |
| ▸ | PDCD1 | Q15116 | 7/20 | 0.63 |
| ▸ | KLKB1 | P03952 | 5/20 | 0.52 |
| ▸ | CIB1 | Q99828 | 4/20 | 0.49 |
| ▸ | EPHA2 | P29317 | 1/20 | 0.49 |
| ▸ | PCSK9 | Q8NBP7 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17810437 | 0.99 | CD274 (0.67) | CD274PDCD1KLKB1CIB1EPHA2 | |
| SCHEMBL16128657 | 0.97 | CD274 (0.66) | CD274PDCD1KLKB1CIB1EPHA2 | |
| SCHEMBL16128596 | 0.97 | CD274 (0.68) | CD274PDCD1KLKB1CIB1EPHA2 | |
| SCHEMBL17810436 | 0.96 | CD274 (0.70) | CD274PDCD1KLKB1CIB1EPHA2 | |
| SCHEMBL16140588 | 0.96 | CD274 (0.69) | CD274PDCD1KLKB1CIB1EPHA2 | |
| SCHEMBL16140591 | 0.96 | CD274 (0.60) | CD274PDCD1KLKB1CIB1EPHA2 | |
| SCHEMBL19340955 | 0.95 | CD274 (0.70) | CD274PDCD1KLKB1CIB1EPHA2 | |
| SCHEMBL19340950 | 0.95 | CD274 (0.70) | CD274PDCD1KLKB1CIB1EPHA2 | |
| SCHEMBL16140549 | 0.95 | CD274 (0.71) | CD274PDCD1KLKB1CIB1PCSK9 | |
| SCHEMBL19340963 | 0.95 | CD274 (0.68) | CD274PDCD1KLKB1CIB1EPHA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9879046-B2 | Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions | BRISTOL-MYERS SQUIBB COMPANY (US) | 2018-01-30 | — | — | US | disclosed |